Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia

Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia

Comprehensive genomic profiling examinations (CGPs) have recently been developed, and a variety of tumor-agnostic mutations have been detected, leading to the development of new molecular-targetable therapies across solid tumors. In addition, the elucidation of hereditary tumors, such as breast and...

Full description

Bibliographic Details
Main Authors: Hironori Arai, Yosuke Minami, SungGi Chi, Yoshikazu Utsu, Shinichi Masuda, Nobuyuki Aotsuka
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Biomedicines
Subjects:
acute myeloid leukemia
tumor agnostic
solid tumor
genomic profiling
hereditary breast and ovarian cancer
variant
Online Access:https://www.mdpi.com/2227-9059/10/12/3008

Internet

https://www.mdpi.com/2227-9059/10/12/3008

Similar Items